IM Cannabis (IMCC) Income from Non-Controlling Interests (2020 - 2025)

IM Cannabis' (IMCC) quarterly Income from Non-Controlling Interests came in at $95266.0 in Q2 2025, up 130.51% year-on-year from $41327.5 in Q2 2024, and up 105.76% quarter-over-quarter from -$1.7 million in Q4 2024.

IM Cannabis (IMCC) Income from Non-Controlling Interests (2020 - 2025) Analysis & Trends

IM Cannabis' Income from Non-Controlling Interests history runs 6 years deep, the most recent figure standing at $95266.0 for Q2 2025.

  • On a quarterly basis, Income from Non-Controlling Interests rose 130.51% year-over-year to $95266.0 in Q2 2025; TTM through Jun 2025 was -$2.2 million, a 428.13% decrease from a year earlier, with the FY2025 full-year figure at -$248111.9, up 71.36% from the prior year.
  • Income from Non-Controlling Interests advanced to $95266.0 in Q2 2025 per IMCC's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $1.0 million in Q1 2024 and bottomed at -$1.7 million in Q4 2024.
  • The 5-year median for Income from Non-Controlling Interests is -$274427.4 (2023), against an average of -$256979.1.
  • Biggest YoY gain for Income from Non-Controlling Interests was 468.32% in 2024; the steepest drop was 826.83% in 2024.
  • Year by year, Income from Non-Controlling Interests stood at -$547401.9 in 2021, then slumped by 113.72% to -$1.2 million in 2022, then surged by 84.74% to -$178492.1 in 2023, then slumped by 826.83% to -$1.7 million in 2024, then surged by 105.76% to $95266.0 in 2025.
  • Per Business Quant, the three latest IMCC Income from Non-Controlling Interests figures stand at $95266.0 (Q2 2025), -$1.7 million (Q4 2024), and -$317412.1 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 395,346.10
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 IM Cannabis 591,792.44 -193,562.09 1.03 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 95,266.05
Dec 31, 2024 -1.65 Mn
Sep 30, 2024 -317,412.13
Jun 30, 2024 -312,197.01
Mar 31, 2024 1.01 Mn
Dec 31, 2023 -178,492.13
Sep 30, 2023 146,948.30
Jun 30, 2023 -183,879.76
Mar 31, 2023 -274,427.35
Dec 31, 2022 -1.17 Mn
Sep 30, 2022 585,027.39
Jun 30, 2022 -271,381.87
Mar 31, 2022 -737,370.03
Dec 31, 2021 -547,401.90
Sep 30, 2021 728,473.34
Jun 30, 2021 -373,408.97
Mar 31, 2021 -914,934.78
Dec 31, 2020 -343,640.49
Sep 30, 2020 324,933.45
Jun 30, 2020 -499,794.34